This website has been developed by Besins Healthcare (UK) Ltd.

This website has separate sections for healthcare professionals (containing promotional information), and patients who have been prescribed Testogel® (testosterone) within the UK.

Please confirm that:

This website is provided for HCPs in the UK by Besins Healthcare (UK) Ltd.

Unexplained anaemia

Ian is fed up not knowing the

cause of his anaemia.

Screening for TD could provide

the answers he’s looking for.

Ian, aged 69

Ian - cancer treatment
Screen me

Patient profile is fictional and for illustrative purposes only.

Screening

Consider screening for testosterone deficiency (TD) in men with a history of anaemia.1

Ian

Screening for TD should form part of a standard anaemia work-up in men1

Guidelines

The Endocrine Society’s Clinical Practice Guidelines recommend measuring testosterone and offering testosterone replacement therapy on an individualised basis for men aged >65 with symptoms or conditions suggestive of TD (including unexplained anaemia), after discussions of the potential risks and benefits.2

Tools for screening

Patients with unexplained anaemia can be screened easily for symptoms of TD using the Androgen Deficiency in Ageing Males (ADAM) questionnaire and/or Ageing Males’ Symptoms (AMS) scale. These tools are simple, effective and can be quickly filled out during a patient appointment, to help you catch symptoms of TD that may not be proactively mentioned by men during follow-up appointments.3

AMS Scale
ADAM questionnaire

If symptoms are present, completing a simple blood test to determine if a patient has low serum testosterone levels can confirm a diagnosis of TD.2,4

References

  1. Al-Sharefi A, Wilkes S, Jayasena CN, et al. How to manage low testosterone level in men: a guide for primary care. Br J Gen Pract. 2020;70(696):364–365.
  2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744.
  3. Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male. 2015;18(1):5–15.
  4. Mulhall JP, Trost LW, Brannigan RE et al. Evaluation and management of testosterone deficiency: AUA Guideline. J Urol. 2018;200(2):423–432.

TES/2020/009. April 2021.

Adverse event reporting

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Besins Healthcare (UK) Ltd Drug Safety on 0203 862 0920 or Email: pharmacovigilance@besins-healthcare.com

Where next...